Bestseller≥ 99.2%

Metabolic & GLP-1
Semaglutide
5 mg · 10 mg
GLP-1 research reference with full identity package
from€68 / vial

Dual GCGR/GLP-1 receptor agonist analogue
Survodutide (BI 456906) is a dual glucagon/GLP-1 receptor agonist studied in hepatic lipid metabolism and energy-expenditure models. Supplied as a 10 mg lyophilized fill at ≥ 99.1% HPLC purity with dual-receptor identity documentation.
88 vials of 10 mg in current lot · ships in 24 h cold-chain
| Format | Lyophilized powder · 3 mL amber vial |
|---|---|
| Net content | 10 mg |
| CAS | 1358161-76-4 |
| Molar mass | 5003.5 g/mol |
| Purity (HPLC) | ≥ 99.1% |
| Storage | Store at –20 °C. Cold-chain shipment included. |

5 mg · 10 mg
GLP-1 research reference with full identity package

10 mg · 20 mg
Dual-incretin reference for next-gen metabolic panels
